Reduced Risk Status: |
THIS AI HAS BEEN CLASSIFIED AS RR FOR ONE OR MORE FOOD USES.
|
IPM Compatibility: |
|
Reasons for need: |
MITES
|
Requesting State(s): |
CA:Zalom, F. ; NC:Sorensen, K. ; NJ:Shearer, P. ; TN:Thompson, A. ;
|
PCR Use Pattern: |
0.1 LB AI/A; ONE APPLICATION; 1-3 DAY PHI
|
EPA Default Residue Trials: |
1 2 3 5 10-3 12
|
IR-4 Residue Trial Plan: |
|
Residue Protocol Use Pattern: |
|
Efficacy/Crop Safety (E/CS) Data Required: |
|
E/CS Research Comments: |
|
Label Use Pattern Submitted To EPA: |
|
EPA PIF Status: |
|
EPA Status: |
|
EPA PRIA Date: |
|
MRID: |
|
Comments: |
SOME EUROPEAN DATA AVAILABLE FROM MFG:11/04; DATA IS FROM 25 TRIALS IN 5 COUNTRIES; MFG TO SEND IR-4 THE FINAL REPORT FOR CONSIDERATION AS SURROGATE DATA IN US:07/07; CHEMSAC SUB ON 8/8/07 TO USE THE EUROPEAN DATA FOR A US TOL OR ALTERNATIVELY A REGIONAL TOL OR REDUCTION IN NUMBER OF TRIALS; CHEMSAC REQUESTED REDUCED US DATA SET FROM 1 FL/2 CA TRIALS WITH SIDE-BY-SIDE COMPARISON OF EC & SC FORMULATIONS; IF RESIDUES ARE SIGNIFICANTLY DIFFERENT BETWEEN FORMULATIONS OR HIGHER THAN EU DATA, ADDITIONAL US TRIALS MAY BE REQUIRED:1/08; MFG SUBMITTED PETITION TO EPA:01/09; MFG TOLERANCE EST:12/09; LABELED:07/10
|
International Status: |
THESE DATA HAVE BEEN SUBMITTED TO ESTABLISH CODEX MRLS, AND CODEX MRLS HAVE BEEN ESTABLISHED.
|
Archive Location: |
|
QA Archive: |
|